Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThat beat expectations for $6.47 billion, according to FactSet. But Moderna turned in per-share...
Family's genes offer clue to delaying onset of Alzheimer's
Richmond Times-Dispatch· 10 hours agoScientists studying a family plagued by early-in-life Alzheimer’s found some carry a genetic oddity...
Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis
Zacks via Yahoo Finance· 3 days agoQuest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption...
FDA expands approval of first gene therapy for rare form of muscular dystrophy
CNN via Yahoo News· 4 hours agoThe US Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation.
Takeaways from AP's report on access to gene therapies for rare diseases
San Francisco Chronicle· 16 hours agoCollectively, about 350 million people worldwide suffer from rare diseases, most of which are ...
Tempus AI shares jump 8% in strong Nasdaq debut as US IPO market thaws
StreetInsider· 6 days ago(Reuters) -Shares of SoftBank Group-backed Tempus AI rose 8.1% in their debut on the Nasdaq on Friday, giving the artificial intelligence-based genetic testing company ...
DNA says you’re related to a Viking, a medieval German Jew or a 1700s enslaved African? What a ...
San Francisco Chronicle· 3 days ago(The Conversation is an independent and nonprofit source of news, analysis and commentary...
A scientific mission to save the sharks
Popular Science via Yahoo News· 5 days agoThis article was originally featured on Knowable Magazine. A hammerhead shark less than one meter long swims frantically in a plastic container aboard a...
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for...
Digital Journal· 3 days agoPartnership Will Aid Physicians in Precision Prescribing Decisions Based on Applied DNA's TR8™ Pharmacogenomic (PGx) Test STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied ...
Goldman Sachs Group Inc. Buys Shares of 415,820 Revvity, Inc. (NYSE:RVTY)
ETF DAILY NEWS· 16 hours agoGoldman Sachs Group Inc. bought a new stake in Revvity, Inc. (NYSE:RVTY – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with ...